GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS)
CNY 13.79
(0.07%)
CNY 13.79
(0.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 278.15 Million | 293.28 Million | 155.03 Million | 63.24 Million | 116.23 Million | 75.34 Million |
| Net Income | 292.7 Million | 191.93 Million | 148.6 Million | 93.95 Million | 133.06 Million | 110.48 Million |
| Depreciation & Amortization | 37.59 Million | 16.19 Million | 11.17 Million | 8.11 Million | 7.53 Million | 7.6 Million |
| Deferred income taxes | -4.16 Million | -40.59 Thousand | -363.87 Thousand | -81.37 Thousand | -764.89 Thousand | - |
| Stock-based compensation | 4.13 Million | 6.3 Million | 756.68 Thousand | 81.37 Thousand | 764.89 Thousand | - |
| Change in working capital | -7.97 Million | 72.19 Million | 2.71 Million | -40.47 Million | -26.05 Million | -46.38 Million |
| Other non-cash items | 47.28 Million | 6.7 Million | -7.84 Million | 1.65 Million | 1.67 Million | 3.64 Million |
| Investing Cash Flow | -495.23 Million | -266.56 Million | 20.59 Million | -292.8 Million | -6.09 Million | -47.59 Million |
| Investments in PPE | -108.73 Million | -119.9 Million | -26.07 Million | -51.7 Million | -8.01 Million | -1.78 Million |
| Acquisitions | -420.99 Million | -159.38 Million | 2.25 Million | 0.07 | 1.91 Million | - |
| Investment purchases | -187 Million | 1.33 | -2.25 Million | -111.9 Million | - | -45.9 Million |
| Sales/Maturities of investments | 181.49 Million | 1.91 Million | 64.61 Million | 798.67 Thousand | - | - |
| Other Investing Activities | 40 Million | 10.81 Million | -17.95 Million | -130 Million | -8.01 Million | 90 Thousand |
| Financing Cash Flow | 217.63 Million | -124.81 Thousand | -81.46 Million | 439.99 Million | -1.96 Million | -76.78 Million |
| Debt repayment | -299 Million | -200 Million | -200 Million | -100 Million | - | - |
| Dividends payments | -40.98 Million | -8.92 Million | -101.83 Million | -2.62 Million | - | -70.38 Million |
| Common Stock Repurchased | -29.99 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -9.93 Million | 208.8 Million | 228.75 Million | 542.61 Million | -1.96 Million | -6.4 Million |
| Accounts receivables | -124.06 Million | -79.55 Million | -83.03 Million | -33.94 Million | -48.22 Million | -5.22 Million |
| Accounts payables | 119.01 Million | 161.24 Million | 127.24 Million | -12.27 Million | 24.4 Million | - |
| Inventory | -7.05 Million | -9.45 Million | -41.12 Million | 5.83 Million | -1.46 Million | -7.77 Million |
| Other working capital | 4.13 Million | -40.59 Thousand | -363.87 Thousand | -81.37 Thousand | -764.89 Thousand | -38.61 Million |
| Cash at beginning of period | 570.88 Million | 544.21 Million | 450.05 Million | 239.61 Million | 131.42 Million | 180.46 Million |
| Cash at end of period | 571.37 Million | 570.81 Million | 544.21 Million | 450.05 Million | 239.61 Million | 131.42 Million |
| Capital Expenditure | -108.73 Million | -119.9 Million | -26.07 Million | -51.7 Million | -8.01 Million | -1.78 Million |
| Effect of forex changes on cash | - | - | 0.68 | 0.32 | -0.27 | 0.32 |
| Net cash flow / Change in cash | 488.47 Thousand | 26.6 Million | 94.16 Million | 210.43 Million | 108.18 Million | -49.03 Million |
| Free Cash Flow | 169.41 Million | 173.38 Million | 128.96 Million | 11.53 Million | 108.22 Million | 73.56 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 77.07 Million | 61.01 Million | 56.04 Million | 292.7 Million | 134.73 Million | 57.01 Million |
| Depreciation & Amortization | - | 19.05 Million | 19.05 Million | 37.59 Million | 10.68 Million | -15.55 Million |
| Deferred income taxes | - | - | - | -4.16 Million | - | -50.92 Million |
| Stock-based compensation | - | 1.23 Million | - | 4.13 Million | 4.13 Million | -2.95 Million |
| Change in working capital | - | -159.19 Million | - | -7.97 Million | -126.98 Million | 69.43 Million |
| Other non-cash items | -10.52 Million | -24.8 Million | -49.68 Million | 47.28 Million | -29.07 Million | 32.35 Million |
| Investing Cash Flow | -49.4 Million | 15.96 Million | -10.64 Million | -495.23 Million | -334.73 Million | -27.21 Million |
| Investments in PPE | -14.69 Million | -13.69 Million | -9.75 Million | -108.73 Million | -8.19 Million | -25.23 Million |
| Acquisitions | -24.19 Million | 24.65 Million | 8000.00 | -420.99 Million | -323.68 Million | 39.99 Thousand |
| Investment purchases | -20 Million | - | -6.39 Million | -187 Million | -177 Million | 1.18 Million |
| Sales/Maturities of investments | 98.75 Thousand | 742.76 Thousand | 255.98 Thousand | 181.49 Million | 181.49 Million | 286.85 Thousand |
| Other Investing Activities | -14.8 Million | 5 Million | 5.5 Million | 40 Million | -7.36 Million | -3.49 Million |
| Financing Cash Flow | -15.97 Million | -80.83 Million | 16.86 Million | 217.63 Million | 265.37 Million | -2.27 Million |
| Debt repayment | -10 Million | -32.57 Million | - | -299 Million | -299 Million | - |
| Dividends payments | -6 Million | -87.04 Million | -5.8 Million | -40.98 Million | -40.98 Million | -2.27 Million |
| Common Stock Repurchased | 444 Thousand | -444 Thousand | - | -29.99 Million | -29.99 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 26.88 Thousand | -110.79 Million | 16.86 Million | -9.93 Million | 37.8 Million | - |
| Accounts receivables | - | -47.58 Million | - | -124.06 Million | -124.06 Million | 5.26 Million |
| Accounts payables | - | - | - | 119.01 Million | - | - |
| Inventory | - | -112.83 Million | - | -7.05 Million | -7.05 Million | 64.17 Million |
| Other working capital | - | 1.23 Million | - | 4.13 Million | 4.13 Million | -2.95 Million |
| Cash at beginning of period | 536.22 Million | 583.96 Million | 571.37 Million | 570.88 Million | 545.76 Million | 486.16 Million |
| Cash at end of period | 537.29 Million | 536.22 Million | 583.96 Million | 571.37 Million | 571.37 Million | 545.76 Million |
| Capital Expenditure | -14.69 Million | -13.69 Million | -9.75 Million | -108.73 Million | -8.19 Million | -25.23 Million |
| Effect of forex changes on cash | - | - | - | - | - | -286.85 Thousand |
| Net cash flow / Change in cash | 1.07 Million | -47.73 Million | 12.58 Million | 488.47 Thousand | 25.6 Million | 59.59 Million |
| Free Cash Flow | 51.85 Million | 3.45 Million | -3.39 Million | 169.41 Million | 86.77 Million | 64.14 Million |
PANABYTE
HEIQ
601233
DUN
HASTIFIN
002841